Подписаться
Pascale Fabbro
Pascale Fabbro
MCU-PH Epidémiologie Santé Publique - Université Montpellier- Faculté de Médecine
Подтвержден адрес электронной почты в домене umontpellier.fr
Название
Процитировано
Процитировано
Год
Mobile phone use and brain tumours in the CERENAT case-control study
G Coureau, G Bouvier, P Lebailly, P Fabbro-Peray, A Gruber, K Leffondre, ...
Occupational and environmental medicine 71 (7), 514-522, 2014
2862014
Evaluation of incidence, clinical significance, and prognostic value of circulating cardiac troponin I and T elevation in hemodynamically stable patients with suspected …
JP Bertinchant, A Polge, D Mohty, R Nguyen-Ngoc-Lam, J Estorc, ...
Journal of Trauma and Acute Care Surgery 48 (5), 924-931, 2000
2602000
Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia
JC Gris, C Chauleur, N Molinari, P Marès, P Fabbro-Peray, I Quere, ...
Thrombosis and haemostasis 106 (12), 1053-1061, 2011
222*2011
Release kinetics of serum cardiac troponin I in ischemic myocardial injury
JP Bertinchant, C Larue, I Pernel, B Ledermann, P Fabbro-Peray, L Beck, ...
Clinical biochemistry 29 (6), 587-594, 1996
2161996
Risk factors of failure and immediate complication of subclavian vein catheterization in critically ill patients
JY Lefrant, L Muller, JE De La Coussaye, M Prudhomme, J Ripart, ...
Intensive care medicine 28, 1036-1041, 2002
2122002
Risk Factors for Antibiotic-ResistantEscherichia coli Isolated from Hospitalized Patients with Urinary Tract Infections: a Prospective Study
A Sotto, CM De Boever, P Fabbro-Peray, A Gouby, D Sirot, J Jourdan
Journal of clinical microbiology 39 (2), 438-444, 2001
2022001
Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor
S Grabar, C Pradier, E Le Corfec, R Lancar, C Allavena, M Bentata, ...
Aids 14 (2), 141-149, 2000
1972000
Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004
L Bauchet, H Mathieu-Daudé, P Fabbro-Peray, V Rigau, M Fabbro, ...
Neuro-oncology 12 (7), 725-735, 2010
1952010
Risk factors for multidrug-resistant Pseudomonas aeruginosa nosocomial infection
C Defez, P Fabbro-Peray, N Bouziges, A Gouby, A Mahamat, JP Daures, ...
Journal of Hospital Infection 57 (3), 209-216, 2004
1932004
Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis
A Sotto, JY Lefrant, P Fabbro-Peray, L Muller, J Tafuri, F Navarro, ...
Journal of Antimicrobial chemotherapy 50 (4), 569-576, 2002
1672002
Comparison of the diagnostic value of cardiac troponin I and T determinations for detecting early myocardial damage and the relationship with histological findings after …
JP Bertinchant, E Robert, A Polge, C Marty-Double, P Fabbro-Peray, ...
Clinica chimica acta 298 (1-2), 13-28, 2000
1672000
GSM radiocellular telephones do not disturb the secretion of antepituitary hormones in humans
R de Seze, P Fabbro‐Peray, L Miro
Bioelectromagnetics: Journal of the Bioelectromagnetics Society, The Society …, 1998
1671998
Clinical implications of clopidogrel non-response in cardiovascular patients: a systematic review and meta-analysis
C Combescure, P Fontana, N Mallouk, P Berdague, C Labruyere, ...
Journal of Thrombosis and Haemostasis 8 (5), 923-933, 2010
1622010
Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris
JP Bertinchant, A Polge, B Ledermann, L Genet, P Fabbro-Peray, ...
The American journal of cardiology 84 (1), 51-57, 1999
1621999
Evaluation of cardiac troponin I and T levels as markers of myocardial damage in doxorubicin-induced cardiomyopathy rats, and their relationship with echocardiographic and …
JP Bertinchant, A Polge, JM Juan, MC Oliva-Lauraire, I Giuliani, ...
Clinica Chimica Acta 329 (1-2), 39-51, 2003
1602003
IN FOCUS: Factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched case–control ‘NOHA first’study
G Lissalde-Lavigne, P Fabbro-Peray, E Cochery-Nouvellon, E Mercier, ...
Journal of Thrombosis and Haemostasis 3 (10), 2178-2184, 2005
1532005
Antiphospholipid/antiprotein antibodies, hemostasis-related autoantibodies, and plasma homocysteine as risk factors for a first early pregnancy loss: a matched case-control study
JC Gris, TV Perneger, I Quéré, E Mercier, P Fabbro-Peray, ...
Blood 102 (10), 3504-3513, 2003
1422003
Pulsed Doppler ultrasonography guidance for catheterization of the subclavian vein: a randomized study
JY Lefrant, P Cuvillon, JF Benezet, M Dauzat, P Peray, G Saissi, ...
The Journal of the American Society of Anesthesiologists 88 (5), 1195-1201, 1998
1411998
Comparative incidence of a first thrombotic event in purely obstetric antiphospholipid syndrome with pregnancy loss: the NOH-APS observational study
JC Gris, S Bouvier, N Molinari, JP Galanaud, E Cochery-Nouvellon, ...
Blood, The Journal of the American Society of Hematology 119 (11), 2624-2632, 2012
1382012
French brain tumor database: 5‐year histological results on 25 756 cases
V Rigau, S Zouaoui, H Mathieu‐Daudé, A Darlix, A Maran, B Trétarre, ...
Brain Pathology 21 (6), 633-644, 2011
1372011
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20